| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.47 | 0.006 |